Abstract:AML (acute myeloid leukemia) is an aggressive hematopoietic malignancy with multiple signaling pathways contributing to its pathogenesis. A key role in of these pathways is the FLT3 (FMS-like tyrosine kinase receptor-3). Activation of the FLT3ITD (internal tandem duplication of FLT3) leads to decreased progression and low survivability rate. Targeting the kinase activity of FLT3 with inhibitory compounds can be used as an obvious therapeutic option. The second generation inhibitors have shown enhanced FLT3 spe… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.